These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31006121)

  • 41. [Specific immunotherapy in allergies--evaluation of current status].
    Jarisch R; Hemmer W
    Wien Med Wochenschr; 1996; 146(15):422-5. PubMed ID: 9012204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of adhesion molecules in human Peyer's patches.
    Brandtzaeg P; Farstad IN
    Gut; 1995 Jun; 36(6):944-5. PubMed ID: 7615293
    [No Abstract]   [Full Text] [Related]  

  • 43. Risk factors for systemic reactions to allergen-specific subcutaneous immunotherapy.
    Iglesias-Cadarso A; Hernández-Weigand P; Reaño M; Pérez-Pimiento A; Vargas Núñez JA; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(7):621-2. PubMed ID: 21314007
    [No Abstract]   [Full Text] [Related]  

  • 44. Allergen injection immunotherapy.
    Varga EM; Durham SR
    Clin Allergy Immunol; 2002; 16():533-49. PubMed ID: 11577558
    [No Abstract]   [Full Text] [Related]  

  • 45. Influence of ofloxacin on murine Peyer's patch lymphocytes.
    De Simone C; Zanzoglu S; Santini G; Ciardi M; Delia S; Sorice F
    Infection; 1986; 14 Suppl 4():S256-7. PubMed ID: 3469157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions.
    Kato H; Fujihashi K; Kato R; Dohi T; Fujihashi K; Hagiwara Y; Kataoka K; Kobayashi R; McGhee JR
    Int Immunol; 2003 Feb; 15(2):145-58. PubMed ID: 12578844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sublingual immunotherapy: dosing in relation to clinical and immunological efficacy.
    Larenas-Linnemann DE
    Allergy Asthma Proc; 2008; 29(2):130-9. PubMed ID: 18430309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Worldwide allergen immunotherapy guidelines: Evidence and experience-based.
    Larenas-Linnemann DES
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():17-22. PubMed ID: 29108768
    [No Abstract]   [Full Text] [Related]  

  • 49. Apple desensitization in two patients with PR-10 proteins allergy.
    Nucera E; Aruanno A; Lombardo C; Patriarca G; Schiavino D
    Allergy; 2010 Aug; 65(8):1060-1. PubMed ID: 19958318
    [No Abstract]   [Full Text] [Related]  

  • 50. Modification of the innate immune function of dendritic cells by allergen-specific immunotherapy.
    Bellinghausen I
    Clin Exp Allergy; 2010 Jan; 40(1):12-4. PubMed ID: 20205693
    [No Abstract]   [Full Text] [Related]  

  • 51. Elevated membrane IgA+ and CD4+ (T helper) populations in murine Peyer's patch and splenic lymphocytes during dietary administration of the trichothecene vomitoxin (deoxynivalenol).
    Pestka JJ; Dong W; Warner RL; Rasooly L; Bondy GS; Brooks KH
    Food Chem Toxicol; 1990 Jun; 28(6):409-20. PubMed ID: 2145206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of humoral immune response to Salmonella typhimurium in mouse Peyer's patches.
    Camacho Villarreal NG; Ventura-Juárez J; Castañeda-Ibarra FJ; Ruiz-Maya L; García-Latorre E; Campos-Rodríguez R
    Rev Latinoam Microbiol; 1995; 37(2):153-60. PubMed ID: 8552875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting.
    Brayden DJ; Jepson MA; Baird AW
    Drug Discov Today; 2005 Sep; 10(17):1145-57. PubMed ID: 16182207
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiated B lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load.
    Gearhart PJ; Cebra JJ
    J Exp Med; 1979 Jan; 149(1):216-27. PubMed ID: 105075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient.
    Nelson HS
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1443-1451. PubMed ID: 27687128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The best allergen immunotherapy choice for mite allergic patients.
    Ciprandi G; Incorvaia C; Masieri S; Buttafava S; Frati F
    Expert Rev Clin Immunol; 2016 Jun; 12(6):603-4. PubMed ID: 26950287
    [No Abstract]   [Full Text] [Related]  

  • 57. Age-dependence of lymphocyte production in Peyer's patch follicles in contrast to the other Peyer's patch compartments and the thymus.
    Rothkötter HJ; Geist M; Fritz FJ; Pabst R
    Adv Exp Med Biol; 1988; 237():81-5. PubMed ID: 3254075
    [No Abstract]   [Full Text] [Related]  

  • 58. Membrane and functional characterization of lymphoid and macrophage populations of Peyer's patches from adult and aged mice.
    Vĕtvicka V; Tlaskalová-Hogenová H; Fornůsek L; Ríhová B; Holán V
    Immunology; 1987 Sep; 62(1):39-43. PubMed ID: 3477526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral immunotherapy: a way forward?
    Platts-Mills TA
    J Allergy Clin Immunol; 1987 Aug; 80(2):129-32. PubMed ID: 2956315
    [No Abstract]   [Full Text] [Related]  

  • 60. Does clinical protection persist after food allergen oral immunotherapy?
    Vickery BP
    Immunotherapy; 2015; 7(8):851-3. PubMed ID: 26314347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.